Target intelligence / Profile preview

C-fiber nociceptor terminal

Molecular classification
Cellular component, Nerve terminal
01

Overview

C-fiber nociceptor terminals are the unmyelinated peripheral endings of primary afferent neurons that specialize in detecting noxious stimuli, including thermal, mechanical, and chemical insults (StatPearls, 2023). These terminals are characterized by a slow conduction velocity and the expression of various specialized receptors and ion channels, such as Transient Receptor Potential (TRP) channels and voltage-gated sodium channels like Nav1.7 and Nav1.8 (Nature Reviews Neurology, 2013). In pathological states, these terminals can become hypersensitized, contributing to chronic and neuropathic pain conditions (NIH, 2021). Therapeutic strategies often target these terminals to provide localized analgesia, either by blocking signal transmission with local anesthetics or by desensitizing the terminals through prolonged activation of TRPV1 receptors (PubMed, 2017). Because they are the primary site of pain initiation, they represent a critical focus for the development of topical and regional pain management therapies (Journal of Pain Research, 2018). Drugs like capsaicin work by initially stimulating and then exhausting these terminals, leading to a period of reduced sensitivity known as defunctionalization (British Journal of Anaesthesia, 2011). Local anesthetics like lidocaine block the sodium channels within these terminals to prevent the propagation of pain signals to the central nervous system (StatPearls, 2023). Monitoring the density of these terminals in the skin via intraepidermal nerve fiber density (IENFD) is a common clinical method for diagnosing small fiber neuropathies (Neurology, 2010).

Other names
Unmyelinated C-fiber terminalC-nociceptorGroup IV afferent nerve endingFree nerve ending
02

Mechanism of action

Modulation of ion channel activity (e.g., TRPV1, Nav1.7) to inhibit action potential generation or induce temporary terminal defunctionalization.

03

Biological functions

NociceptionThermoreceptionChemoreceptionSignal transduction
04

Disease associations

Neuropathic painChronic painPruritusInflammation
05

Safety considerations

Application site erythemaBurning sensationPotential for localized sensory lossRisk of neurotoxicity with high-potency agonists
06

Interacting drugs

Capsaicin

5 more in the full profile.

07

Biomarkers

Intraepidermal nerve fiber density (IENFD)Quantitative sensory testing (QST)

Beyond the preview

Go deeper on C-fiber nociceptor terminal.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on C-fiber nociceptor terminal.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call